Rankings
▼
Calendar
VCEL FY 2018 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$91M
+42.1% YoY
Gross Profit
$59M
64.6% margin
Operating Income
-$4M
-4.3% margin
Net Income
-$8M
-9.0% margin
EPS (Diluted)
$-0.20
Cash Flow
Operating Cash Flow
-$412,000
Free Cash Flow
-$3M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$119M
Total Liabilities
$16M
Stockholders' Equity
$102M
Cash & Equivalents
$18M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$91M
$64M
+42.1%
Gross Profit
$59M
$34M
+74.8%
Operating Income
-$4M
-$15M
+73.9%
Net Income
-$8M
-$17M
+52.9%
← Q4 2017
All Quarters
Q1 2018 →